We are live on ! Find out more
UTMD icon

Utah Medical Products
UTMD

63 hedge funds and large institutions have $147M invested in Utah Medical Products in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 30 increasing their positions, 17 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

76% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 17

3% more funds holding

Funds holding: 61 → 63 (+2)

1% more capital invested

Capital invested by funds: $146M → $147M (+$1.71M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
63
Holders Change
+2
Holders Change %
+3.28%
% of All Funds
1.7%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
4
Increased
30
Reduced
17
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AA
Ancora Advisors
Ohio
+$1.47M
2
RFC
Russell Frank Company
Washington
+$752K
3
CYG
Clean Yield Group
Vermont
+$520K
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$464K
5
OCG
Opus Capital Group
Ohio
+$283K

Top Sellers

Rank Fund Capital Flow
1
MDCM
Morgan Dempsey Capital Management
Wisconsin
-$537K
2
BIT
BlackRock Institutional Trust
California
-$297K
3
BFA
BlackRock Fund Advisors
California
-$280K
4
American Century Companies
American Century Companies
Missouri
-$109K
5
Northern Trust
Northern Trust
Illinois
-$76.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
51
Deutsche Bank
Germany
$55K +$52.3K +930 +93,000%
PCM
52
Prelude Capital Management
New York
$51K -$25.3K -450 -35%
Royal Bank of Canada
53
Royal Bank of Canada
Ontario, Canada
$34K +$16.9K +300 +108%
SO
54
STRS Ohio
Ohio
$23K – – –
PNC Financial Services Group
55
PNC Financial Services Group
Pennsylvania
$20K +$844 +15 +5%
BCA
56
Bray Capital Advisors
Florida
$20K +$18.6K +330 New
BNP Paribas Financial Markets
57
BNP Paribas Financial Markets
France
$18.7K +$12.7K +225 +256%
TRCT
58
Tower Research Capital (TRC)
New York
$15K +$1.29K +23 +10%
Bank of America
59
Bank of America
North Carolina
$15K +$13.6K +241 +2,008%
Invesco
60
Invesco
Georgia
$6K +$1.35K +24 +34%
JG
61
Jefferies Group
New York
$5K +$4.73K +84 New
Barclays
62
Barclays
United Kingdom
$3K -$3.04K -54 -48%
Manulife (Manufacturers Life Insurance)
63
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$135 -$19.6K -349 -13%
Creative Planning
64
Creative Planning
Kansas
– -$7K -120 Closed
AllianceBernstein
65
AllianceBernstein
Tennessee
– -$6K -100 Closed
1 2
3

UTMD Hedge Fund Activity: Q2 2015 in Review

63 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q2 2015, worth a combined $147M — up 1.2% from $146M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new UTMD positions and 2 closed out — a net gain of 2 holders — while 30 added to existing stakes and 17 trimmed.

The largest buyer was Ancora Advisors, opening a new position worth an estimated $1.47M. The largest seller was Morgan Dempsey Capital Management, cutting an estimated $537K.

  • 63 institutional investors held Utah Medical Products (UTMD) as of Q2 2015, up from 61 in Q1 2015.
  • Funds reported $147M of Utah Medical Products stock for Q2 2015, up 1.2% quarter-over-quarter.
  • 4 funds opened new Utah Medical Products positions in Q2 2015 and 2 closed out, a net change of +2 holders.
  • The largest Utah Medical Products buyer in Q2 2015 was Ancora Advisors, an estimated $1.47M added.
  • The largest Utah Medical Products seller in Q2 2015 was Morgan Dempsey Capital Management, an estimated $537K sold.

Based on aggregated 13F filings for Q2 2015.